Adam Ang
Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.
This comes five years after Advent Partners and Geoffrey Sayer, who became its CEO, bought the company.
Also, Japan has approved one of JLK's stroke imaging AI solutions.
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
The company has received 12 US FDA approvals.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The Orthopaedic Surgery team has recently received an international patent for the novel AI for robotic total knee replacement.
The Australian-led project developed these maps, claimed to be the most detailed ever made, to link retinal thinning to various diseases.
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.